Comparison of Prescribing Pattern of Anti-hypertensive Drugs and the Level of Control Achieved in Type 2 Diabetes Patients between Primary and Tertiary Care Hospitals
Abstract
Hypertension is a common co-morbidity of diabetes affecting majority of people with diabetes, also a major risk factor for coronary vascular disease and microvascular complications such as retinopathy and nephropathy. To compare prescribing pattern of anti-hypertensive drugs and the level of control of hypertension achieved in type 2 diabetes patients in primary and tertiary care hospitals. Fifty patients each with type 2 diabetes and hypertension (fulfilling JNC 7 criteria for diagnosis of hypertension) attending the out-patient departments of primary and tertiary health care centers in Bangalore were included in the study. Data regarding blood pressure and type of drugs used were collected. Two blood pressure readings were taken with a time span of 5 min on each individual in sitting position. Average of the two readings was recorded. Only 34(68%) of patients were on treatment at primary care level where as 48(96%) were on treatment at tertiary care level. At the primary care level calcium channel blockers (CCBs) 20(40%) were the most common drug used followed by Angiotensin converting enzyme inhibitors (ACEI) 8(16%). At tertiary care level ARBs 22(44%) were the most commonly used drugs followed by ACE inhibitors 14(28%). Only 8(16%) were well controlled in primary care level whereas 34(68%) were well controlled at tertiary care level. Prescribing pattern of anti-hypertensives and level of control of hypertension at primary care level grossly deviates from available recommendations as compared to tertiary care level.
Keywords: anti-hypertensive drugs, type 2 diabetes mellitus, prescribing patterns, primary and tertiary health care levels
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |